Improving Patient Experience, Enhancing Data-Driven Insights, and Optimising Clinical Trial Performance

28 January 2025 | Copthorne Tara Hotel, London Kensington, UK

As the global clinical trial market is going through rapid growth, it is predicted that by 2025, 40% of all trials will incorporate decentralised elements. For that reason, it has become increasingly crucial to advance technology usage in clinical trials.

Although technological advancements in clinical trials such as AI and wearables can lead to great benefits such as increased operational efficiency, patient satisfaction and the ease of data collection, implementing more technology can be costly, complex, and difficult to navigate.

Join us at the 3rd Disruptive Technology for Clinical Trials Summit Europe alongside clinical trial industry leaders as they share their insights on successfully leveraging disruptive technologies to improve clinical trial innovation.

2025 European Clinical Trial Technology Expert Speakers Include:

Andrew Gvozdanovic of Novo Nordisk speaking at AMG World

Andrew Gvozdanovic

International Medical Manager

Novo Nordisk

Piotr Maślak of AstraZeneca speaking at AMG World

Piotr Maślak

Director, Operational Data Intelligence

AstraZeneca

Dr Fabian Kreimendahl of The Janssen Pharmaceutical Companies of Johnson & Johnson speaking at AMG World

Dr Fabian Kreimendahl

Medical Evidence Biostatistics Manager

The Janssen Pharmaceutical Companies of Johnson & Johnson

Dr Sachin S Shah of GSK speaking at AMG World

Dr Sachin S Shah

Digital Biomarker Lead

GSK

Marcus Greenhill of Analog Devices speaking at AMG World

Marcus Greenhill

Sales Director Digital Healthcare (Pharma) Systems EMEA

Analog Devices

Samantha Warden of GSK speaking at AMG World

Samantha Warden

Global Head, Clinical Programming & Business Excellence

GSK

Nathan Noakes of Parexel speaking at AMG World

Nathan Noakes

Sensor Solutions Director

Parexel

Guido Radack of Bayer speaking at AMG World

Guido Radack

Former VP of Digital Transformation in Clinical Development

Bayer

Ming-Yuang Tseng MD PHD of AstraZeneca speaking at AMG World

Ming-Yuang Tseng MD PHD

Director Global Regulatory Affairs (CVRM)

AstraZeneca

Alexandre Malouvier of ICON PLC speaking at AMG World

Alexandre Malouvier

Senior Director Scientific Affairs & Digital Innovation

ICON PLC

Dr Daphne Hazell of Home Wound Care speaking at AMG World

Dr Daphne Hazell

CEO

Home Wound Care

Cristina De Juan PhD of UCB speaking at AMG World

Cristina De Juan PhD

Global Clinical Sciences & Operations Innovation Lead

UCB

Marta Carrasco of Roche speaking at AMG World

Marta Carrasco

Data Insights Development Leader

Roche

Paul Cooper of Roche speaking at AMG World

Paul Cooper

Healthcare Strategy Leader

Roche

Key Themes Include:

Attending this event will enable you to:

  • Foster a Culture of Innovation: Build an organisational culture that embraces technological advancements and innovation in clinical trials to create an environment of continuous innovation.

 

  • Harness Cutting-Edge Innovations: Discover how remote monitoring tools, wearables, and AI can revolutionise study recruitment, clinical trial delivery, and study outcomes.

 

  • Enhance the Patient Experience: Boost patient engagement using digital solutions, such as e-PRO, eCOA, eConsent, and more to enhance patient satisfaction and compliance.

 

  • Optimise Data Strategies: Leverage innovative tools to enhance data capture and analysis for more real-time, accurate insights into the progress of study participants.

 

  • Measure Value: Track key performance indicators pre- and post-technology implementation to prove ROI and enhance long-term success.

Who You Will Meet:

VPs, Directors, Heads, Managers from:

  • Clinical R&D / Operations
  • Clinical Trial Innovation
  • Clinical Development
  • Digital Health / Digital Medicine
  • DCT / Decentralised clinical trials / hybrid trials
  • Patient Experience, Patient Engagement / Patient-centred Outcomes
  • Regulatory / Clinical Affairs
  • Biostatistics / biomarkers / bioinformatics / data generation / data strategy

Our sponsors include technology, service and solution providers specialising in:

  • Remote-monitoring tools
  • Wearables / Biosensors
  • Data Analytics Software & Platforms
  • Patient Experience Management Platforms / Mobile & Web Applications
  • AI (Artificial Intelligence) / ML (Machine Learning
  • ePRO / Electronic patient-reported outcome
  • eCOA / Electronic Clinical Outcome Assessment
  • eSource / Electronic Data Capture / DDC Direct Data Capture
  • eConsent / Digital Enrolment

Disruptive Technologies for Clinical Trials Europe Sponsorship Opportunities

Get in touch to position your organisation as a clinical trials technology expert amongst the most prominent and influential players in the development of Disruptive Technologies, IoT, Wearables, Data & Analytics, and AI/ML to senior decision makers.

2025 Sponsors

Testimonials

GSK

Great interactive event indeed ; was pleased not only to attend but being able to share my own experience and meet colleagues and similarly interested people on the use of automation and AI/ML to accelerate drug development ! Thank you again for the event

Director R&D / GSK

Reckitt

Thanks for a great interactive event! Thanks for organising.

Senior IT Business Relationship Manager / Reckitt

AstraZeneca

It was a great meeting with lots to mull over. Thanks.

Director / AstraZeneca

Abbvie

It was great to participate in the panel discussion on the challenges and opportunities for developing smart labs and industrial automation in sustainable manner. Thanks AMG for the invite.

Director, Head of Enabling Technology Development Group / Abbvie

Amgen

Congratulations on conducting a great event! Many thanks for engaging me with it.

Director, Global Research (Biologics) / Amgen

Content Highlights

Top 10 Takeaways: Ethical Implications of AI Use Infographic

Panellists from Novartis, ICON PLC, and Astellas Pharma explored the ethical implications of AI use in clinical trials, paying attention to emerging risks, key considerations, and future trends. If you missed the discussion, we’re pleased to share our top 10 takeaways from this collaborative discussion. From the importance of transparency in AI systems to the… Read more »

Ethical Implications of AI Use in Clinical Trials Virtual Roundtable Discussion

The use of artificial intelligence in clinical trials holds immense promise, from accelerating drug discovery to optimizing patient recruitment and trial design. However, the integration of AI also introduces complex ethical considerations that must be carefully navigated. Watch the recording as panellists from Novartis, ICON PLC, and Astellas Pharma explored the ethical implications of AI… Read more »

Disruptive Technology for Clinical Trials Europe 2025 Sponsorship Pack

Complete the form below to view the sponsorship information for Disruptive Technology for Clinical Trials Europe 2025 in London, UK on 28 January 2025. Full Name(Required) First Last Job Title(Required)Company Name(Required)Email(Required) Country AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic... Read more »

Whitepaper: Harnessing the Full Potential of Real-World Data and Evidence to Enhance Clinical Trial Design and Effectiveness

This whitepaper explores the transformative potential of real-world data and evidence in clinical trials, with industry experts sharing their key insights on integrating diverse data sources to enhance trial design, recruitment, and outcomes. Clinical trial technology specialists from AstraZeneca, Parexel, Novartis and GSK examine key challenges in data quality and regulatory compliance, while outlining strategies… Read more »